Lipid profiles for nevirapine vs. atazanavir/ritonavir, both combined with tenofovir disoproxil fumarate and emtricitabine over 48 weeks, in treatment-naïve HIV-1-infected patients (the ARTEN study) - Concepedia

Concepedia

Publication | Closed Access

Lipid profiles for nevirapine vs. atazanavir/ritonavir, both combined with tenofovir disoproxil fumarate and emtricitabine over 48 weeks, in treatment-naïve HIV-1-infected patients (the ARTEN study)

37

Citations

31

References

2011

Year

Daniel Podzamczer, Jaime Andrade‐Villanueva, Bonaventura Clotet, Stephen Taylor, JK Rockstroh, Peter Reiss, Peré Domingo, HJ Gellermann, L. de Rossi, Victoria Cairns,

Abstract

In ARV-naïve patients with low CR at the outset, NVP showed a potentially less atherogenic lipid profile compared with ATZ/r.

References

	Year	Citations

Page 1